Search for Clinical Trial Results
Carcinoma, Ductal - 50 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Effects of Diet and Exercise on Ductal Carcinoma in Situ Condition:
Date: 2014-08-19 Interventions:
|
Terminated |
Study Name: Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast Condition: Ductal Carcinoma in Situ of the Breast Date: 2005-09-09 Interventions: Other: Observation Wide excision of DCIS and a minimum of 1cm histologically negative margin of breast t |
Terminated |
Study Name: Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer Condition: Ductal Carcinoma Date: 2007-04-17 Interventions:
|
Active, not recruiting |
Study Name: Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer Condition:
Date: 2005-09-12 Interventions:
|
Active, not recruiting |
Study Name: The Significance of MRI in the Development of Diagnostics and Treatment of Breast Cancer Condition: Mammary Ductal Carcinoma Date: 2011-11-30 |
Active, not recruiting |
Study Name: A Feasibility Study for Women Receiving Anthracycline Chemotherapy With or Without Radiation for HER2-neu Positive Invasive Ductal Carcinoma Condition: Breast Cancer Date: 2014-05-12 Interventions: Other: Feasibility study All participants will have blood draws for biomarkers during the course of the |
Completed |
Study Name: Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast Cancer Condition:
Date: 2011-12-15 Interventions: Procedure: axillary dissection Conservative breast surgery with or without axillary dissection |
Completed |
Study Name: Contribution of 18FDG PET-Scan in Tumour Volume Determination in Patients Operated of Breast Cancer Condition: Infiltrating Ductal Carcinoma Date: 2012-06-14 |
Recruiting |
Study Name: Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer Condition:
Date: 2014-04-28 Interventions: Drug: Intranasal Oxytocin Intranasal spray, one spray or 4 IU of oxytocin will be administered into each |
Active, not recruiting |
Study Name: Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma Condition: Renal Cell Carcinoma Date: 2012-12-22 Interventions:
|